For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

Lundbeck: Alzheimer's agitation drug can make a real difference

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Ask the Pharmacist: New drug treats Alzheimer's agitation

Alzheimer's Agitation Seen to Ease with Schizophrenia Drug

Statement on the FDA Approval of Brexpiprazole

REXULTI® (brexpiprazole) agitation that may happen with dementia

JAMA Neurology Publishes Complete Results of Positive Phase 3

Decision on Brexpiprazole for Alzheimer's Agitation Due in May

Rexulti Full Prescribing Information, Dosage & Side Effects

Schizophrenia drug promising for Alzheimer's agitation - Seasons

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Why REXULTI® (brexpiprazole) agitation that may happen with

FDA advisory committee vote in favor of Lundbeck and Otsuka's